These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17668337)

  • 21. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
    Ruan Y; Qin G; Yin L; Chen K; Qian HZ; Hao C; Liang S; Zhu J; Xing H; Hong K; Shao Y
    AIDS; 2007 Dec; 21 Suppl 8():S39-46. PubMed ID: 18172390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus.
    Currie SL; Ryan JC; Tracy D; Wright TL; George S; McQuaid R; Kim M; Shen H; Monto A
    Drug Alcohol Depend; 2008 Jan; 93(1-2):148-54. PubMed ID: 17977668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs).
    Miller CL; Strathdee SA; Li K; Kerr T; Wood E
    Am J Drug Alcohol Abuse; 2007; 33(4):527-36. PubMed ID: 17668338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection.
    Hagan H; Des Jarlais DC; Stern R; Lelutiu-Weinberger C; Scheinmann R; Strauss S; Flom PL
    Int J Drug Policy; 2007 Oct; 18(5):341-51. PubMed ID: 17854721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring associations between perceived HCV status and injecting risk behaviors among recent initiates to injecting drug use in Glasgow.
    Palmateer N; Anderson N; Wadd S; Hutchinson S; Taylor A; Goldberg D
    Subst Use Misuse; 2008; 43(3-4):375-88. PubMed ID: 18365938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between first injection risk behaviors and hepatitis C seropositivity among injecting drug users.
    Vidal-Trecan GM; Varescon-Pousson I; Gagnière B; Tcherny- Lessenot S; Madariaga E; Boissonnas A
    Ann Med Interne (Paris); 2002 Jun; 153(4):219-25. PubMed ID: 12218887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in HIV risk behaviors by gender in a sample of Tanzanian injection drug users.
    Williams ML; McCurdy SA; Atkinson JS; Kilonzo GP; Leshabari MT; Ross MW
    AIDS Behav; 2007 Jan; 11(1):137-44. PubMed ID: 17004117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008.
    Iversen J; Wand H; Gonnermann A; Maher L;
    Int J Drug Policy; 2010 Nov; 21(6):471-6. PubMed ID: 20472417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
    Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. cities.
    Bailey SL; Ouellet LJ; Mackesy-Amiti ME; Golub ET; Hagan H; Hudson SM; Latka MH; Gao W; Garfein RS;
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S18-29. PubMed ID: 17434267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "I inject less as I have easier access to pipes": injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed.
    Leonard L; DeRubeis E; Pelude L; Medd E; Birkett N; Seto J
    Int J Drug Policy; 2008 Jun; 19(3):255-64. PubMed ID: 18502378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tattooing in prisons--not such a pretty picture.
    Hellard ME; Aitken CK; Hocking JS
    Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Injecting drug users' understanding of hepatitis C.
    O'Brien S; Day C; Black E; Dolan K
    Addict Behav; 2008 Dec; 33(12):1602-5. PubMed ID: 18762384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An outbreak of hepatitis B virus infection among methamphetamine injectors: the role of sharing injection drug equipment.
    Vogt TM; Perz JF; Van Houten CK; Harrington R; Hansuld T; Bialek SR; Johnston R; Bratlie R; Williams IT
    Addiction; 2006 May; 101(5):726-30. PubMed ID: 16669906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of hepatitis C infection in injecting drug users in Zadar County, Croatia.
    Medić A; Dzelalija B; Sonicki Z; Zekanović D
    Coll Antropol; 2008 Sep; 32(3):697-702. PubMed ID: 18982740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Injecting practices in sexual partnerships: hepatitis C transmission potentials in a 'risk equivalence' framework.
    Harris M; Rhodes T
    Drug Alcohol Depend; 2013 Oct; 132(3):617-23. PubMed ID: 23664125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventing hepatitis C: what do positive injectors do?
    Carruthers SJ
    Drug Alcohol Rev; 2005 Mar; 24(2):193-8. PubMed ID: 16076589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of HCV in a cohort of injectors on methadone substitution treatment.
    Lee KC; Lim WW; Lee SS
    J Clin Virol; 2008 Apr; 41(4):297-300. PubMed ID: 18191614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus (HCV)--specific T cell responses in injection drug users with apparent resistance to HCV infection.
    Thurairajah PH; Hegazy D; Chokshi S; Shaw S; Demaine A; Kaminski ER; Naoumov NV; Cramp ME
    J Infect Dis; 2008 Dec; 198(12):1749-55. PubMed ID: 18959498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anatomy of risk: a quantitative investigation into injection drug users' taxonomy of risk attitudes and perceptions.
    Marsch LA; Bickel WK; Badger GJ; Quesnel KJ
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):195-203. PubMed ID: 17469943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.